Do patients undergoing cytoreductive surgery and HIPEC for peritoneal malignancy need parenteral nutrition? [0.03%]
腹膜恶性肿瘤细胞减灭术和HIPEC患者需要肠外营养吗？
David R Swain,Allison L Yates,Faheez Mohamed et al.
David R Swain et al.
Background: To analyse the duration of parenteral nutrition (PN) in patients treated for peritoneal malignancy with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) over a 2 year period at...
Biphasic learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy:technical competence and refinement of patient selection [0.03%]
腹腔减瘤术及术后温热腹腔内化疗的学习曲线：技术成熟度和患者选择标准的优化
Nicholas B Shannon,Grace Hwei Ching Tan,Claramae Shulyn Chia et al.
Nicholas B Shannon et al.
Background: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is routinely used for selected patients with peritoneal metastasis, but can be associated with high complication rates, prolon...
Founding of the International Society for the Study of Pleura and Peritoneum (ISSPP) [0.03%]
国际胸膜与腹膜学会的成立
Marc A Reymond
Marc A Reymond
Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design [0.03%]
腹腔镜下使用加压式气溶胶腹腔热灌注化疗序贯全身化疗奥沙利铂剂量爬坡的I/II期临床研究（PIPOX试验）治疗消化道肿瘤（胃、小肠和结直肠）不耐手术的腹膜转移：逻辑与设计
Frédéric Dumont,Hélène Senellart,Francois Pein et al.
Frédéric Dumont et al.
Background: The annual incidence of gastrointestinal carcinomas (stomach, small bowel, colon and rectum) is increasing in Western countries, reaching 50,000 new cases each year in France. Peritoneal carcinomatosis (PC) is...
Study protocol: phase 1 dose escalating study of Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) with oxaliplatin in peritoneal metastasis [0.03%]
腹腔转移瘤使用奥沙利铂进行加压腹膜内化疗（PIPAC）Ⅰ期爬坡剂量研究方案
Guowei Kim,Hon Lyn Tan,Elya Chen et al.
Guowei Kim et al.
Background: Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) is a novel laparoscopic intraperitoneal chemotherapy technique, with advantages such as homogeneous distribution of aerosol and deeper tissue penetrati...
PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer [0.03%]
腹膜内压化化疗（PIPAC）与单纯化疗对铂耐药复发性上皮卵巢癌、输卵管癌或原发性腹膜癌患者无进展生存期影响的多中心、开放标签、随机、两组III期临床试验(PIPAC-OV3)
Naoual Bakrin,Clemens Tempfer,Giovanni Scambia et al.
Naoual Bakrin et al.
Background: Recurrent, platin-resistant ovarian cancer (rPROC) has a poor survival. Even with the AURELIA trial, which is the best available treatment today, progression-free survival (PFS) is still only 6.7 months from t...
Randomized control trial comparing quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) and intravenous chemotherapy [0.03%]
随机对照试验：对于晚期腹膜转移患者，与静脉化疗相比，加压腹腔内气溶胶化学治疗（PIPAC）对患者生活质量的影响评估
S P Somashekhar,K R Ashwin,C Amit Rauthan et al.
S P Somashekhar et al.
Background: Peritoneal metastasis (PM) is a common occurrence in gynaecological and gastrointestinal cancers and is associated with poor survival. Patients typically present with ascites, abdominal pain, malnutrition, nau...
Martin Hübner
Martin Hübner
PIPAC EstoK 01: Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study [0.03%]
腹腔热灌注化疗(PIPAC C/D)治疗胃癌腹膜转移的多中心二期临床试验：一项随机对照研究
Clarisse Eveno,Ingrid Jouvin,Marc Pocard
Clarisse Eveno
Background: Peritoneal metastasis (PM) from gastric cancer often remains undiagnosed until it reaches an advanced stage. Despite curative management combining perioperative systemic chemotherapy, cytoreductive surgery (CR...
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo naïve upper gi-adenocarcinomas with peritoneal seeding - a phase II/III trial of the AIO/CAOGI/ACO [0.03%]
腹腔内药物喷雾化疗（PIPAC）与标准治疗联合用于未经治疗的胃上部腺癌腹膜转移患者：AIO/CAOGI/ACO二期/三期临床试验
Thorsten Oliver Goetze,Salah-Eddin Al-Batran,Urs Pabst et al.
Thorsten Oliver Goetze et al.
Background: Peritoneal metastasis is a common and dismal evolution of several gastrointestinal (GI) tumors, including gastric, colorectal, hepatobiliary, pancreatic, and other cancers. The therapy of peritoneal metastasis...